Bharat Rasayan

Why is Bharat Rasayan Ltd falling/rising?

As of 08-Aug, Bharat Rasayan Ltd's stock price is currently 1,360.00, reflecting a decline of -0.92%. The stock has significantly underperformed over the past year and three years, with declining investor participation and poor long-term growth prospects.

As of 08-Aug, Bharat Rasayan Ltd's stock price is falling, currently at 1,360.00, reflecting a change of -12.65 (-0.92%). The stock has been underperforming in the short term, having lost -1.65% over the last two days. Additionally, it has underperformed its sector by -0.52% today. <BR><BR>In terms of longer-term performance, the stock has generated a return of -48.60% over the past year and -41.62% over the last three years, significantly lagging behind the BSE500 index. The company's operating profit has also declined at an annual rate of -4.17% over the last five years, indicating poor long-term growth prospects.<BR><BR>Investor participation appears to be declining, with delivery volume on August 6 falling by -56.54% compared to the five-day average. Although the stock is trading at a discount compared to its peers and has shown some positive financial metrics, such as a growth in profits and a low debt-to-equity ratio, these factors have not been sufficient to counteract the overall negative sentiment and performance trends.

Which are the latest news on Bharat Rasayan?

Should I buy, sell or hold Bharat Rasayan Ltd?

How big is Bharat Rasayan?

As of 10th June, Bharat Rasayan Ltd has a market capitalization of 2,353.00 Cr, with recent net sales of 1,241.84 Cr and a net profit of 145.72 Cr. The company reported shareholder's funds of 1,130.00 Cr and total assets of 1,408.14 Cr for the annual period ending March 2025.

As of 10th June, Bharat Rasayan Ltd has a market capitalization of 2,353.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest 4 quarters, Bharat Rasayan reported Net Sales of 1,241.84 Cr and a Net Profit of 145.72 Cr.<BR><BR>For the latest annual period ending March 2025, the company reported Shareholder's Funds of 1,130.00 Cr and Total Assets of 1,408.14 Cr.

Who are in the management team of Bharat Rasayan?

The management team of Bharat Rasayan includes S N Gupta (Chairman & Managing Director), Mahabir Prasad Gupta, Rajender Prasad Gupta, Ajay Gupta (all Whole-Time Directors), and several Independent Non-Executive Directors, along with Nikita Chadha as Company Secretary. This team is responsible for the company's governance and strategic direction.

The management team of Bharat Rasayan includes the following key individuals:<BR><BR>1. **S N Gupta** - Chairman & Managing Director<BR>2. **Mahabir Prasad Gupta** - Whole-Time Director & Executive Director<BR>3. **Rajender Prasad Gupta** - Whole-Time Director & Executive Director<BR>4. **Ajay Gupta** - Executive Director & Whole-Time Director<BR>5. **Kamleshwar Prasad Uniyal** - Executive Director<BR>6. **Pankaj Gupta** - Independent Non-Executive Director<BR>7. **Ram Kanwar** - Independent Non-Executive Director<BR>8. **Sujata Agarwal** - Independent Non-Executive Director<BR>9. **Suresh Kumar Garg** - Independent Non-Executive Director<BR>10. **Ankit Aggarwal** - Independent Non-Executive Director<BR>11. **Nikita Chadha** - Company Secretary<BR><BR>This team plays a crucial role in the governance and strategic direction of the company.

Who are the peers of the Bharat Rasayan?

Bharat Rasayan's peers include Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., Insecticid.India, India Pesticides, Astec Lifescienc, and Meghmani Organi. Sharda Cropchem shows excellent management and growth, while Bharat Rasayan has average management risk and below-average growth, with a 1-year return of -38.30%.

Peers: The peers of Bharat Rasayan are Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., Insecticid.India, India Pesticides, Astec Lifescienc, and Meghmani Organi.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sharda Cropchem and Dhanuka Agritech, while Average management risk is found at Rallis India, NACL Industries, Bhagiradha Chem., Bharat Rasayan, Insecticid.India, and India Pesticides, and Below Average management risk is noted at Astec Lifescienc and Meghmani Organi. Growth is Excellent at Sharda Cropchem, while Below Average growth is seen at Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., Bharat Rasayan, Insecticid.India, India Pesticides, Astec Lifescienc, and Meghmani Organi. Excellent capital structure is noted for Sharda Cropchem, Dhanuka Agritech, Rallis India, Bharat Rasayan, Insecticid.India, and India Pesticides, while Good capital structure is found at Bhagiradha Chem., Average at Meghmani Organi, and Below Average at NACL Industries and Astec Lifescienc.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sharda Cropchem at 8.30%, while the peer with the lowest is Dhanuka Agritech at -36.93%. Bharat Rasayan's 1-year return is -38.30%, which is lower than Sharda Cropchem's but higher than Dhanuka Agritech's. Additionally, peers with negative six-month returns include Dhanuka Agritech, Rallis India, NACL Industries, Astec Lifescienc, and Meghmani Organi.

What does Bharat Rasayan do?

Bharat Rasayan Ltd is a small-cap company in the pesticides and agrochemicals sector, primarily manufacturing pesticides and intermediates. As of March 2026, it reported net sales of ₹308 Cr and a net profit of ₹38 Cr, with a market cap of ₹2,353 Cr.

Overview:<BR>Bharat Rasayan Ltd is a small-cap company in the pesticides and agrochemicals industry, primarily engaged in the manufacturing of pesticides and their intermediates.<BR><BR>History:<BR>Bharat Rasayan Limited was incorporated as a Public Limited Company on May 15, 1989. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 308 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 38 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 2,353 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 15.00<BR>- Industry P/E: 29<BR>- Dividend Yield: 0.03%<BR>- Debt Equity: -0.21<BR>- Return on Equity: 12.52%<BR>- Price to Book: 1.84<BR><BR>Contact Details:<BR>Address: 1501 Vikram Tower, Rajendra Place New Delhi New Delhi : 110008<BR>Tel: 91-11-41538383/43661111<BR>Email: invester.brl@bharatgroup.co.in<BR>Website: http://www.bharatgroup.co.in

Are Bharat Rasayan Ltd latest results good or bad?

Bharat Rasayan Ltd's latest results show a 51.81% year-on-year increase in net profit to ₹38.15 crores, but a 4.70% decline from the previous quarter. While there are positive trends in profit and margins, long-term growth challenges and declining return on equity suggest caution for investors.

Bharat Rasayan Ltd's latest results present a mixed picture. For the quarter ending March 2026, the company reported a net profit of ₹38.15 crores, which is a significant increase of 51.81% year-on-year. However, this figure reflects a decline of 4.70% compared to the previous quarter, indicating some loss of momentum.<BR><BR>Net sales for the same quarter were ₹308.02 crores, showing a slight year-on-year growth of 0.49% and a notable quarter-on-quarter increase of 13.89%. The operating margin improved to 16.27%, up from 13.11% a year earlier, which suggests enhanced operational efficiency.<BR><BR>Despite the positive year-on-year profit growth, it's important to note that the company has faced challenges over the longer term, including a five-year average sales growth of just 2.56% and a concerning EBIT contraction of 3.65% annually. The return on equity (ROE) has also declined to 12.04%, below its five-year average of 15.82%, raising concerns about shareholder value creation.<BR><BR>Overall, while the latest quarterly results show some positive trends, particularly in profit and margins, the longer-term performance metrics and market conditions suggest that the company is navigating significant challenges in the agrochemical sector. Investors may want to approach with caution, considering both the recent improvements and the underlying structural issues.

Is Bharat Rasayan technically bullish or bearish?

As of November 26, 2025, the trend is mildly bullish with supportive MACD signals, but caution is advised due to bearish weekly KST and Bollinger Bands, alongside a lack of momentum in the RSI.

As of 26 November 2025, the technical trend has changed from sideways to mildly bullish. The current stance is mildly bullish, supported by bullish MACD signals on both the weekly and monthly time frames, and a bullish daily moving average. However, the weekly KST is mildly bearish and the Bollinger Bands indicate a sideways trend on the weekly, with a bearish monthly outlook. The RSI shows no signals on both time frames, indicating a lack of momentum. Overall, while there are bullish indicators, the presence of bearish signals in other areas suggests caution.

How has been the historical performance of Bharat Rasayan?

Bharat Rasayan's historical performance shows fluctuating financial metrics, with net sales increasing to 1,173.00 Cr in March 2025 but declining from 1,234.34 Cr in March 2023. Despite rising costs, operating profit improved to 200.90 Cr, and profit after tax rose to 125.10 Cr, indicating a mixed performance with growth in sales and profits.

Answer:<BR>The historical performance of Bharat Rasayan shows fluctuations in key financial metrics over the years, with notable trends in revenue, profit, and assets.<BR><BR>Breakdown:<BR>Bharat Rasayan's net sales reached 1,173.00 Cr in March 2025, an increase from 1,044.63 Cr in March 2024, but a decline from 1,234.34 Cr in March 2023. The total operating income followed a similar trend, peaking at 1,301.15 Cr in March 2022 before decreasing in subsequent years. The company's total expenditure, excluding depreciation, was 998.12 Cr in March 2025, up from 927.36 Cr in March 2024, reflecting rising raw material costs which were 824.54 Cr in March 2025. Operating profit (PBDIT) was 200.90 Cr in March 2025, showing an increase from 138.17 Cr in March 2024, although it was lower than the 266.67 Cr recorded in March 2022. Profit before tax stood at 169.19 Cr in March 2025, compared to 109.42 Cr in March 2024, while profit after tax was 125.10 Cr, up from 81.61 Cr in the previous year. The company's total assets increased to 1,408.14 Cr in March 2025 from 1,197.45 Cr in March 2024, with total liabilities also rising to 1,408.14 Cr. Cash flow from operating activities improved to 172.00 Cr in March 2025, up from 41.00 Cr in March 2024, indicating a positive cash flow trend. Overall, Bharat Rasayan's financial performance reflects a mix of growth in sales and profits alongside rising costs and liabilities.

Is Bharat Rasayan overvalued or undervalued?

As of August 11, 2025, Bharat Rasayan is considered very expensive and overvalued with a PE ratio of 33.63, elevated valuation metrics compared to industry norms, and a PEG ratio of 0.71, despite outperforming the Sensex in the short term.

As of 11 August 2025, Bharat Rasayan's valuation grade has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is currently considered overvalued. Key ratios include a PE ratio of 33.63, an EV to EBITDA of 25.95, and a Price to Book Value of 4.19, which are all elevated compared to industry norms.<BR><BR>In comparison to its peers, Bharat Rasayan's PE ratio is lower than P I Industries at 35.18 and Bayer CropScience at 42.61, but higher than UPL, which has a PE of 34.55. The PEG ratio of 0.71 suggests some growth potential, yet the overall high valuation metrics indicate that the stock may not offer a favorable risk-reward profile at this time. Notably, while Bharat Rasayan has outperformed the Sensex in the short term, its longer-term performance has lagged, further supporting the view that it is currently overvalued.

Who are the top shareholders of the Bharat Rasayan?

The top shareholders of Bharat Rasayan include Sat Narain Gupta, the largest promoter with 23.83%, followed by Ritesh Stock Broking Private Limited at 4.72%, mutual funds with 2.55%, and foreign institutional investors holding 0.49%. Individual investors collectively own 11.23% of the shares.

The top shareholders of Bharat Rasayan include the promoters, who hold the majority of the shares. The promoter with the highest holding is Sat Narain Gupta, with 23.83%. Additionally, Ritesh Stock Broking Private Limited is the highest public shareholder, owning 4.72%. The company also has mutual funds holding 2.55% through two schemes, and foreign institutional investors (FIIs) hold 0.49% across 32 entities. Individual investors collectively own 11.23% of the shares.

When is the next results date for Bharat Rasayan?

No Upcoming Board Meetings

Has Bharat Rasayan declared dividend?

Yes, Bharat Rasayan Ltd. has declared a 15% dividend, amounting to ₹1.5 per share, with an ex-date of September 12, 2024. However, the company has experienced significant declines in price returns over various periods, indicating challenges in stock performance despite the dividend announcement.

Bharat Rasayan Ltd. has declared a 15% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 12 Sep 24<BR><BR>Dividend Yield: 0.02%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -22.48%, with a dividend return of 0%, resulting in a total return of -22.48%.<BR><BR>Over the past year, the price return was -14.14%, with a dividend return of 0.01%, leading to a total return of -14.13%.<BR><BR>In the 2-year period, the price return was -9.81%, with a dividend return of 0.03%, resulting in a total return of -9.78%.<BR><BR>For the 3-year period, the price return was -23.53%, with a dividend return of 0.04%, leading to a total return of -23.49%.<BR><BR>In the last 4 years, the price return was -31.16%, with a dividend return of 0.05%, resulting in a total return of -31.11%.<BR><BR>Over the 5-year period, the price return was 27.37%, with a dividend return of 0.10%, leading to a total return of 27.47%.<BR><BR>Overall, while Bharat Rasayan has declared a dividend, the total returns over various periods show significant declines in price returns, particularly in the shorter time frames, suggesting challenges in stock performance despite the dividend declaration.